Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. With $1.9 billion under management and offices in North America and Europe, Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, nearly 40 Versant companies have achieved successful acquisitions or IPOs.

Versant in Europe

Versant Ventures has a team in Basel, Switzerland, dedicated to working with entrepreneurs, industry and leading academics across Europe. The team has decades of experience in the pharmaceutical and biotechnology industries, including global roles in drug discovery, research and product development for companies such as Roche, Novartis and Lilly. Versant’s Basel office is led by Tom Woiwode, Guido Magni, Gianni Gromo and Carlo Rizzuto.